Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases. Their proprietary ON-OFF switches and synthetic Notch receptors provide T-cells with a far greater capability to recognize cancer and other disease tissues in a precise and controlled manner. This new toolkit for cellular engineering opens up the possibility to expand the use of cell therapies and provide treatments with unprecedented power, precision, safety, and durability. Acquired by: Gilead Sciences